Rabbit Anti-Human A1CF pAb
-
Product Number
PA6708
-
Alias
A1CF, ACF, ACF64, ACF65, APOBEC1CF, ASP
-
Specifications
- 50ul
- 100ul
Product Description
| Alias | A1CF, ACF, ACF64, ACF65, APOBEC1CF, ASP |
| Catalog Number | PA6708 |
| Molecular Name | A1CF |
| Host | Rabbit |
| Size | 50ul, 100ul |
| Clonity | Polyclonal |
| Purification | Affinity Purification |
| Formulation | Supply in PBS with 0.02% sodium azide, 50% glycerol, pH 7.4. |
| Immunogen | Recombinant fusion protein containing a sequence corresponding to a.a. 50-120 of human A1CF (NP_055391.2). |
| Application | WB, IHC |
| Storage Condition | Store the product under sterile conditions after opening at -20℃. Avoid freeze-thaw cycles. |
| Shipping Condition | Shipped on ice packs. |
| Product Declaration | 本产品仅用于研究用途(RUO)。不能用于诊断或直接用于人体实验。 |
| Product Full Name | Rabbit Anti-Human A1CF Polyclonal Antibody |
FAQ
-
Q1- A1CF（APOBEC1 Complementation Factor）的主要功能是什么？
A1CF与APOBEC1共同介导RNA编辑，尤其在脂蛋白代谢中发挥重要作用。
-
Q2- 抗体是否适用于细胞内染色（如流式细胞术）？
需先进行细胞透化处理（如0.1% Triton X-100），具体方案参考技术手册。
-
Q3- 抗体的批次间一致性如何保证？
每批次抗体均通过ELISA效价检测和WB验证，确保稳定性（批号见标签）。
-
Q4- 如何处理抗体浓度过高导致的背景噪音？
提高封闭时间（≥1小时），并增加洗涤次数（如TBST 3×10分钟）。
-
Q5- 是否提供大包装规格（如1mg）？
支持定制大包装，请联系销售团队获取报价和交货时间。
- Protein Platform
- Protein Expression Services
- Protein Modification & Detection Services
- Protein Interaction Services
- Protein Purification Service
- Antibody Discovery Platform
- VHH Antibody Platform
- Phage Display Platform
- Antibody Humanization Platform
- Single B Cell Screening Platform
- Antibody Expression & Validation Platform
- Peptide Library Platform
- Custom Antibody Platform
- Innovative Drug Discovery Platform
- Product Center
- Proteins
- Antibodies
- Raw Materials Reagents
- Small Molecule Reagents
- Peptide Products
- Nanoparticle Products
- Contact Us
- Phone：400-621-6806
- Mobile：13110936064（WeC
- E-mail：[email protected]
- Address：Room 108, Building 10, No. 6 Hechang Road, Wuqing Development Zone, Tianjin City
-
WeChat
-
Service Account
-
400-621-6806 -
3599163699 -
Monday to Friday 9:00-18:00 -
-
0
-
